Updated guidelines from the ESC and EAS for the management of dyslipidemia include new, more aggressive proposed goals for LDL-C levels; revised CV risk stratification, particularly for patients at high to very high risk; and new patient management recommendations. These include the following:
For patients at high risk (10-year risk for CV death of 5% to < 10%): Use an LDL-C reduction of at least 50% from baseline and an LDL-C goal < 1.8 mmol/L (< 70 mg/dL).
For very high-risk patients who experience a second vascular event within 2 years (not necessarily of the same type as the first event) while taking maximally tolerated statin therapy: An LDL-C goal < 1.0 mmol/L (< 40 mg/dL) may be considered.
For individuals at moderate risk (10-year risk for CV death of 1% to < 5%): Consider an LDL-C goal < 2.6 mmol/L (< 100 mg/dL).
For individuals at low risk (10-year risk for CV death < 1%): Consider an LDL-C goal < 3.0 mmol/L (< 116 mg/dL).
Other recommendations include consideration of cardiovascular imaging for assessment of atherosclerotic CVD risk, such as assessment of carotid and/or femoral arterial plaque burden on arterial ultrasonography as a risk modifier in individuals at low or moderate risk. Similarly, CAC score assessment with CT can be considered as a risk modifier in the CV risk assessment of asymptomatic individuals at low or moderate risk.
Learn more about the management of CVD risk.
Medscape © 2020 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Yasmine S. Ali. Fast Five Quiz: Cardiovascular Disease Risk Management in Women - Medscape - Dec 14, 2020.